Health|May 26, 2026|1 min read

Kyle Diamantas as Acting FDA Commissioner: Wins Trust and Exceeds Expectations

Kyle Diamantas, the acting FDA commissioner, has earned significant trust and exceeded expectations in his role leading the regulatory agency during a critical period.

#fda#kyle-diamantas#acting-commissioner#regulatory-agency#healthcare-policy

STAT News

Contributor

Share this story

Trump administration advances plan for peptide drugs favored by RFK Jr.

The Trump administration is moving forward with a plan to allow specialty pharmacies to produce certain peptides, largely unregulated injections that have gained popularity among followers of Health Secretary Robert F. Kennedy Jr. and wellness influencers. The plan submitted to the Office of Management and Budget aims to ease access to peptides like BPC-157 through enforcement discretion.